DENTSPLY SIRONA Inc.

DENTSPLY SIRONA Inc.

XRAY
DENTSPLY SIRONA Inc.US flagNASDAQ
10.92
USD
+0.14
- -
2.19BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
20.68
20.62
19.1
17.18
17.41
17.77
18.03
15.23
19.37
18.2
18.7
18.67
18.46
18.24
Basic EPS, GAAP
2.2
2.28
1.79
1.97
-6.76
-4.51
1.15
-0.33
1.88
-4.41
-0.62
-4.48
-3
-2.73
Free Cash Flow per Basic Share
2.92
3.91
3.55
2.58
2.59
2.21
2.86
2.96
3.01
2.4
1.78
2.27
1.18
1.6
Dividend per Share
0.24
0.26
0.29
0.3
0.34
0.35
0.36
0.4
0.42
0.48
0.55
0.62
0.64
0.48
Book Value per Share
17.81
16.47
16.69
35.26
29.17
22.96
23.01
22.55
22.98
17.7
15.89
9.77
6.71
6.74
Tangible Book Value per Share
-3.81
-3.11
-1.79
-3.46
-3.19
-3.28
-2.17
-7.12
-5.98
-3.62
-4.1
-4.34
-3.92
-3.28
Basic Weighted Avg Shares
143
142
140
218
229
224
223
219
218
216
212
203
199
200
Sales/Revenue/Turnover
2,951
2,923
2,674
3,745
3,993
3,986
4,022
3,339
4,231
3,922
3,965
3,793
3,680
3,643
Operating Margin (%)
14.66
15.63
16.45
12.76
12.87
8.76
10.79
6.92
14.77
9.28
7.29
4.96
6.85
5.05
Depreciation Expense
128
129
123
272
316
331
323
334
346
328
343
349
352
349
Net Income, GAAP
313
323
251
430
-1,550
-1,011
256
-73
411
-950
-132
-910
-598
-546
Effective Tax Rate (%)
14.13
20.05
23.35
2.15
- -
- -
24.26
- -
24.59
- -
- -
- -
- -
50
Profit Margin (%)
10.61
11.05
9.39
11.48
-38.81
-25.36
6.36
-2.19
9.71
-24.22
-3.33
-23.99
-16.25
-14.99
Working Capital
347
554
721
976
1,048
875
1,005
426
591
723
548
157
680
743
LT Debt
1,166
1,150
1,141
1,511
1,612
1,565
1,553
2,108
2,062
1,975
1,921
1,677
2,108
2,084
Total Equity
2,578
2,322
2,339
8,126
6,628
5,133
5,095
4,935
4,997
3,812
3,294
1,943
1,340
1,351
Return on Invested Capital (%)
9.43
9.5
9.45
7.06
- -
- -
4.85
- -
6.38
- -
- -
- -
- -
- -
Return on Capital (%)
8.97
9.44
8.31
7.05
- -
- -
4.1
- -
6.23
- -
- -
- -
- -
-8.2
Return on Common Equity (%)
13.2
13.3
10.78
8.23
-21.04
-17.23
5.01
-1.46
8.28
-21.57
-3.72
-34.77
-36.45
-32.98

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
360
230
228
LT Borrowings
2,015
2,006
1,996
LT Finance Leases
93
95
88
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
200
200
200
Market Capitalization
2,281
2,323
2,125

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,023
1,845
1,928
Cash, Cash Equivalents & STI
326
190
239
Accounts Receivable, Net
688
622
620
Inventories
642
659
665
Total Current Liabilities
1,343
1,207
1,185
Payables & Accruals
590
977
957
ST Debt
360
230
228
Deferred Revenue
74
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
9.44%
-21.62%
-31.03%
Free Cash Flow
-4.12%
-14.78%
-49.02%
Net Income, GAAP
-120.32%
-105.03%
-34.29%
Sales/Revenue/Turnover
4.36%
2.64%
-2.98%
Total Cash Common Dividend
13.41%
7.87%
1.59%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
953
984
951
905
3,793
2025
879
936
904
961
3,680
2026
880
898
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.09
-0.02
-2.46
-2.16
-4.48
2025
0.1
-0.23
-2.14
-0.73
-3
2026
-0.05
0.19
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.14
0.16
0.16
0.16
0.62
2025
0.16
0.16
0.16
0.16
0.64
2026
0.16
- -
- -
- -
- -

Company Description

CEO
Daniel T. Scavilla
Full Time Employees
14,000
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
13320 Ballantyne Corporate Place Charlotte NC United States of America 28277-3607
IPO Date
Aug 12, 1987
Business
DENTSPLY SIRONA Inc. DENTSPLY SIRONA Inc. develops, manufactures, and markets a comprehensive portfolio of professional dental products and technologies worldwide, serving dental professionals, laboratories, clinics, and distributors in more than 150 countries. The company, formed by the 2016 merger of DENTSPLY International (founded in 1899 in New York City) and Sirona Dental Systems (founded in 1877 in Erlangen, Germany) and headquartered in Charlotte, North Carolina, offers end-to-end solutions including CAD/CAM systems such as CEREC Primescan, Primemill, and inLab; digital imaging with Orthophos, GALILEOS, and XIOS sensors; treatment centers like Axano, INTEGO, and SINIUS; implants via Astra Tech, Ankylos, and DS OmniTaper systems; consumables encompassing restoratives (SureFil, Celtra Duo, Spectra), endodontics (ProTaper Ultimate, WaveOne Gold, TruNatomy), orthodontics (SureSmile aligners), and infection prevention products; laboratory equipment including CEREC Speedfire furnaces and inFire HTC; handpieces and instruments under the Midwest brand; hygiene systems like DAC Universal; and healthcare consumables through Wellspect such as urological catheters. DENTSPLY SIRONA Inc. operates across key segments including connected technology solutions, essential dental equipment, and consumables, targeting general dentists, specialists, oral surgeons, periodontists, endodontists, and orthodontic practices with a focus on digital dentistry, innovation, and clinical education. In recent strategic developments, the company completed a review of alternatives for its Wellspect Healthcare subsidiary in September 2025 and elected to retain it for enhanced long-term value, amid a multi-year transformation emphasizing operational efficiencies, customer engagement, and portfolio optimization; appointed Aldo M. Denti as Executive Vice President and Chief Commercial Officer in October 2025 to strengthen commercial leadership and align business units; launched innovations like Primescan 2, DS Core platform, Primeprint 3D printing solutions, and enhancements to SureSmile aligners and X-Smart Pro+ endodontic motor; and expanded clinical education through DS World events and DS Academy Campus while advancing sustainability initiatives under the BEYOND program and partnerships like Smile Train.

Company News

  • New At-Home Surity™ Urinary Management System Designed to Provide Comfort and Reliable Care for People Living with Urinary Incontinence

  • Empowered Funds LLC Grows Stake in DENTSPLY SIRONA Inc. $XRAY

  • DENTSPLY SIRONA Q2 Earnings Call Highlights

  • XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales

  • Here's What Key Metrics Tell Us About Dentsply (XRAY) Q2 Earnings

  • DENTSPLY SIRONA Inc. (XRAY) Q2 2026 Earnings Call Transcript

  • Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates

  • Dentsply Sirona Reports Second Quarter 2026 Results

  • Arkadios Wealth Advisors Purchases New Stake in DENTSPLY SIRONA Inc. $XRAY

  • DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?

  • Dimensional Fund Advisors LP Raises Stake in DENTSPLY SIRONA Inc. $XRAY

  • Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship

  • Dentsply Sirona to Host Second Quarter Conference Call on August 6th

  • DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Consensus Rating of “Hold” from Brokerages

  • PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry

  • Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now

  • Dentsply Sirona Appoints John Fortson as Chief Financial Officer

  • Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Dentsply (XRAY) Down 13.5% Since Last Earnings Report: Can It Rebound?